The 25% boost in ViroPharma Inc. 's share price stayed steady but support for Shire plc started to slide toward the breakeven point in Monday morning trades as investors digested the prospects of a merger between the two biotechnology companies.
Philadelphia Business Journal (blog) - Jan 15, 2014
Shire said Wednesday it has waived the Office of Fair Trading approval condition that was part of its previously announced $50 per share tender offer for all of the outstanding shares of ViroPharma Inc. The London-based Office of Fair Trading [OFT] is ...
Sept. 13 (Bloomberg) -- ViroPharma Inc., a producer of drugs that treat rare diseases, has attracted interest from suitors including European drugmakers Sanofi and Shire Plc, said people with knowledge of the process. ViroPharma's shares surged.
Philadelphia Business Journal (blog) - Dec 31, 2013
Shire has extended its previously announced tender offer for all of the outstanding common shares of ViroPharma until midnight on Jan. 9. All of the other terms and conditions of the $50 per share tender offer remain unchanged.